Medpace Holdings, Inc.

By person

16 insiders · 603 transactions

6,620×

August J. Troendle holds 6,620 times base salary in stock. $6.21B of shares against $937.42K in salary for 2025.

Salary from the company's own proxy. The shares are what August J. Troendle last reported holding, valued at $620.27, the price Common Stock was last bought or sold at on the open market here, on 27 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Troendle August J.

President & CEO

$154.56M (17)

$1.38B (230)

−$1.23B

10,005,932

35.85%

$6.21B

−34.0%

Medpace Limited Partnership entity

10% owner

—

$998.48M (6)

−$998.48M

0.0000%

$0.00

−100.0%

Medpace Investors, LLC entity

10% owner

$154.56M (17)

$999.64M (179)

−$845.08M

4,733,019

16.96%

$2.94B

−48.6%

GEIGER JESSE J

President

—

$83.46M (22) scheduled

−$83.46M

15,000

0.0537%

$9.30M

—

BURWIG SUSAN E

Exec. VP, Operations

—

$61.14M (17)

−$61.14M

62,984

0.2257%

$39.07M

+227.9%

EWALD STEPHEN P

General Counsel & Corp. Secy.

$652.22 (1)

$33.36M (15) scheduled

−$33.36M

20,343

0.0729%

$12.62M

—

Kraft Robert O.

Director

—

$15.18M (6) scheduled

−$15.18M

955

0.0034%

$592.36K

—

Brady Kevin M.

CFO & Treasurer

—

$11.87M (7) scheduled

−$11.87M

12,830

0.0460%

$7.96M

+156.6%

DAVENPORT FRED B JR

Director

$72.90K (1)

$8.41M (3) scheduled

−$8.33M

5,798

0.0208%

$3.60M

+286.5%

Carley Brian T

Director

—

$4.43M (2)

−$4.43M

27,825

0.0997%

$17.26M

—

McCarthy Cornelius P. III

Director

—

$1.93M (3)

−$1.93M

12,275

0.0440%

$7.61M

—

Keating Ashley M.

Director

—

$1.69M (8) scheduled

−$1.69M

250

0.0009%

$155.07K

—

King Tom C

Director

—

$79.60K (2) scheduled

−$79.60K

598

0.0021%

$370.92K

—

Brown Bruce

Director

—

9,295

0.0333%

$5.77M

—

BUCKNELL PENELOPE J

VP, Human Resources

—

3,000

0.0107%

$1.86M

—

Fifth Cinven Fund (No. 1) Limited Partnership entity

10% owner

—

0.0000%

$0.00

−100.0%

Individual transactions

Insider

Date

Role

Action

Price

Amount

GEIGER JESSE J

5 Nov 2025

President

Sold on a plan

21,503

$595.66

$12.81M

Medpace Investors, LLC

21 Sep 2023

10% owner

Sold on a plan

61,655

$244.27

$15.06M

Troendle August J.

21 Sep 2023

CEO

Sold on a plan indirect

61,655

$244.27

$15.06M

Medpace Investors, LLC

20 Sep 2023

10% owner

Sold on a plan

65,653

$255.48

$16.77M

Troendle August J.

20 Sep 2023

CEO

Sold on a plan indirect

65,653

$255.48

$16.77M

Troendle August J.

19 Sep 2023

CEO

Sold on a plan indirect

137,379

$259.66

$35.67M

Medpace Investors, LLC

19 Sep 2023

10% owner

Sold on a plan

137,379

$259.66

$35.67M

Troendle August J.

18 Sep 2023

CEO

Sold on a plan indirect

53,385

$274.76

$14.67M

Medpace Investors, LLC

18 Sep 2023

10% owner

Sold on a plan

53,385

$274.76

$14.67M

Medpace Investors, LLC

8 Jun 2023

10% owner

Sold on a plan

49,347

$220.85

$10.90M

Troendle August J.

8 Jun 2023

CEO

Sold on a plan indirect

49,347

$220.85

$10.90M

Medpace Investors, LLC

7 Jun 2023

10% owner

Sold on a plan

110,324

$223.05

$24.61M

Troendle August J.

7 Jun 2023

CEO

Sold on a plan indirect

110,324

$223.05

$24.61M

Medpace Investors, LLC

6 Jun 2023

10% owner

Sold on a plan

58,681

$220.46

$12.94M

Troendle August J.

6 Jun 2023

CEO

Sold on a plan indirect

58,681

$220.46

$12.94M

Medpace Investors, LLC

25 Apr 2023

10% owner

Sold on a plan

31,648

$221.83

$7.02M

Troendle August J.

25 Apr 2023

CEO

Sold on a plan indirect

31,648

$221.83

$7.02M

Showing 250 of 603 transactions. The figures above use every one of them.

By person

Individual transactions

What was left out